105 related articles for article (PubMed ID: 10516)
21. [Long-term treatment of coronary heart disease with concomitant hypertension. Oxycardin retard in the coronary hypertensive patient].
Tuluweit K; Strauss G
ZFA (Stuttgart); 1983 Mar; 59(7):388-94. PubMed ID: 6845862
[No Abstract] [Full Text] [Related]
22. [Hemodynamic and coronary effects of isosorbide dinitrate, by the intravenous route, before and after the cold test in chronic coronary insufficiency treated with a beta-blocker].
Merillon JP; Zygelman M; Curien N; Evstigneff T; Pansard Y; Aumont MC; Gourgon R
Therapie; 1983; 38(1):71-9. PubMed ID: 6135260
[No Abstract] [Full Text] [Related]
23. [Effect of oxycardin on the intraocular pressure].
Trif V; Oancea I
Med Welt; 1978 Jun; 29(26):1100-4. PubMed ID: 27693
[No Abstract] [Full Text] [Related]
24. [Therapy of anginose disorders using the combination beta blockader Prindolol and isosorbide dinitrate. A comparative double-blind cross-over study].
Szám I; Kerkovits G; Buday G
Med Monatsschr; 1974 Sep; 28(9):400-3. PubMed ID: 4608972
[No Abstract] [Full Text] [Related]
25. Benefits from adding nifedipine to the treatment of unstable angina when beta-blockade and isosorbide dinitrate have proved inadequate.
Hagemeijer F; van Mechelen R; Santoso T
Herz; 1982 Apr; 7(2):126-31. PubMed ID: 6806163
[TBL] [Abstract][Full Text] [Related]
26. [The treatment of ambulant hypertensive patients with a combination of a saluretic and a beta-receptor blocker (author's transl)].
Schlesinger P; Fadel Tabet F
MMW Munch Med Wochenschr; 1981 Oct; 123(42):1589-92. PubMed ID: 6118831
[No Abstract] [Full Text] [Related]
27. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
Di Prisco AU; Vaccari GL; Soro A; Mora A
Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
Kirichenko AA; Aslibekian IS; Ivanova LN; Zurabian KM
Klin Med (Mosk); 1985 Oct; 63(10):88-92. PubMed ID: 2867247
[No Abstract] [Full Text] [Related]
29. [Coronary disease. Clinical experience with a new active substance combination].
Bouzo H
Med Welt; 1977 Dec; 28(49):2001-7. PubMed ID: 340839
[No Abstract] [Full Text] [Related]
30. Effect of drugs on myocardial perfusion scanning and wall motion in patients with coronary insufficiency.
Simon H; Felix R; Hedde J
Acta Med Scand Suppl; 1978; 615():85-91. PubMed ID: 358767
[No Abstract] [Full Text] [Related]
31. [Effect of bupranolol in combination with isosorbide dinitrate in bronchial diseases].
Buchegger G; Vankov T
Med Welt; 1982 Mar; 33(10):376-8. PubMed ID: 7087714
[No Abstract] [Full Text] [Related]
32. [Proceedings: Clinical experiences with a new beta adrenergic blocking agent KO 1366 (0-[2-hydroxy-3-(tertiarybutylamino)-propoxy]-benzonitrile-hydrochloride)].
Fujise S; Takada T; Osanai S; Abe H
Jpn Circ J; 1975 Jun; 39(6):736-7. PubMed ID: 239261
[No Abstract] [Full Text] [Related]
33. [Drug therapy of coronary heart disease (author's transl)].
Kaltenbach M
Arzneimittelforschung; 1977; 27(3a):703-7. PubMed ID: 17415
[No Abstract] [Full Text] [Related]
34. [Drug therapy of coronary disease. What is assured and what is possible in general practice?].
Nossen J
MMW Munch Med Wochenschr; 1980 May; 122(22):36-7. PubMed ID: 6104785
[No Abstract] [Full Text] [Related]
35. [Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
Korkushko OV; Shatilo VB; Butenko AG
Sov Med; 1989; (12):66-8. PubMed ID: 2483591
[No Abstract] [Full Text] [Related]
36. [Long-term study with Stenoptin in general practice].
Kessler H
Med Welt; 1980 Jan; 31(4):149-51. PubMed ID: 6154224
[No Abstract] [Full Text] [Related]
37. [Duration of effect and dose-response relationship of a new beta-sympatholytic agent in comparison with pindolol in patients with coronary heart disease].
Becker HJ; Matthäus EJ; Kaltenbach M
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1690-4. PubMed ID: 19897
[No Abstract] [Full Text] [Related]
38. [Clinical evaluation of nadolol in coronary disease].
Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
[No Abstract] [Full Text] [Related]
39. [Clinical experiences with treating coronary artery disease with adrenergic beta receptor blockaders].
Szulc EJ
Wiad Lek; 1972 Dec; 25(23):2093-7. PubMed ID: 4405150
[No Abstract] [Full Text] [Related]
40. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
Wlazłowski R; Kruszyński G; Goch JH
Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
